CBD for Anxiety: Insights from Neuroimaging Studies
This cbd neuroimaging anxiety review analyzes 12 human studies comparing CBD with placebo in stress and anxiety contexts. The evidence shows inconsistent brain-imaging results and very low certainty, with self-reported anxiety rarely differing from…
Blog: Can AI-Clinician Collaboration Improve Medical Care?
AI-clinician collaboration can improve medical care when machines extend pattern recognition and clinicians preserve context, verification, and accountability. Evidence suggests that combined performance can improve in defined tasks, but poor advice,…
Blog: How True Information Becomes Misleading in Medicine
How true information becomes misleading is often less about factual error than about context being stripped away. This essay explores how memory, diagnosis, genetics, and medical research can remain technically accurate while teaching the wrong lesson.…
Cannabis and Parkinson’s Disease: What a New Evidence Review Shows
A recent systematic review evaluated cannabis sativa Parkinsons motor symptoms and found Grade A evidence indicating no motor benefit. This review clarifies cannabis sativa's role in Parkinson's motor symptom treatment. It highlights the need for careful…
CED Cannabis Science Digest: Cannabis and Tobacco Co-Use Across Brain, Youth, and Cessation Research
Three peer-reviewed studies examine cannabis and tobacco co-use across brain imaging, youth nicotine dependence, and cessation research. The findings support better screening and longitudinal study. They do not establish causation or treatment efficacy.
Blog: What the Autism Spectrum Wheel Can and Cannot Show
The autism spectrum wheel offers a more accurate picture than placing autistic people on a single line from mild to severe. It can display differences in communication, sensory experience, flexibility, relationships, daily function, strengths, and…
CED Cannabis Science Digest: Nociplastic Pain, Edible Safety, and HHC Metabolism
This digest reviews cannabis-based medicines nociplastic pain evidence alongside edible safety and HHC metabolism findings. The focus is on educational signals, not treatment proof. Understanding these distinctions aids safer clinical counseling.
Medicinal Cannabis and Fibromyalgia: Endocannabinoid Biomarkers Trial
This fibromyalgia endocannabinoid biomarkers trial evaluated whether oral THC:CBD cannabis oil changes blood markers in women with fibromyalgia. The study found no significant changes in plasma PEA, OEA, or SEA levels compared to placebo. These results…
Blog: What Cannabinoid Safety for Autistic Children Requires
Cannabinoid safety for autistic children requires more precision than broad claims about cannabis and autism. Randomized trials of purified CBD and CBD-dominant formulations have produced mixed results, including negative primary outcomes alongside…
Medicinal Cannabis in Advanced Cancer: What the New RESONANCE Trial Protocol Will Actually Test
The RESONANCE trial cannabis cancer protocol outlines a rigorous Phase I/II study testing medicinal cannabis for safety, tolerability, and symptom control in advanced cancer. This randomized, placebo-controlled trial aims to clarify cannabis's impact on…